Disc Medicine Funding: $153M Raised, Series B (2021)
Disc Medicine is based in Cambridge, Mass.. It has raised $153M in total funding. Latest round: Series B.
Disc Medicine funding overview
Disc Medicine is based in Cambridge, Mass.. Disc Medicine has raised $153M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in September 2021. The round record for Disc Medicine runs through 2021; nothing later has been disclosed. Investors on record include OrbiMed, Arix Bioscience, Janus Henderson Investors, 5AM Ventures, Rock Springs Capital, Nantahala Capital Management and 6 others. 12 distinct backers are named across the disclosed rounds.
Disc Medicine at a glance
Total raised
$153M
Latest round
Series B
Latest round date
September 2021
Headquarters
Cambridge, Mass.
Notable investors
OrbiMed, Arix Bioscience, Janus Henderson Investors, 5AM Ventures, Rock Springs Capital, Nantahala Capital Management, Willett Advisors, Alexandria Venture Investments
Frequently asked about Disc Medicine funding
How much has Disc Medicine raised?
Disc Medicine has raised $153M in total disclosed funding across the rounds on record.
Who has invested in Disc Medicine?
OrbiMed, Arix Bioscience, Janus Henderson Investors, 5AM Ventures, Rock Springs Capital, Nantahala Capital Management are named among the investors backing Disc Medicine.
What was the latest Disc Medicine funding round?
The most recent disclosed round is a Series B, announced in September 2021.
Where is Disc Medicine based?
Disc Medicine is based in Cambridge, Mass..
When did Disc Medicine last raise?
The last disclosed Disc Medicine round closed in September 2021 at Series B.
Round data for Disc Medicine is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.
